Radiation therapy triggering the immune system
Posted: 15 April 2024 Peter Mac researcher Dr Benjamin Blyth is studying how radiation therapy can trigger an immune response in the body the way a vaccine does. Understanding this could lead to new treatments that optimise the use of…
New international study finds triple-negative breast cancer patients could avoid chemotherapy
Posted: 15 April 2024 Peter Mac researchers are part of a major international study that has found patients with early-stage triple-negative breast cancer (TNBC) and high levels of immune cells could be spared from intensive chemotherapy regimens. TNBC…
Honouring the achievements and dedication of Australian health and medical researchers
Posted: 15 April 2024 In a ceremony attended by the Minister for Health and Aged Care, the Hon Mark Butler MP, the Council Chair, Professor Caroline Homer AO, and members of NHMRC’s Council, as well as other distinguished…
WEHI helps spearhead changes to global anaemia guidelines
Posted: 15 April 2024 The way anaemia is diagnosed worldwide could change for the first time in 50 years, following a landmark study led by WEHI researchers. The findings have been used by the World Health Organization (WHO)…
The OCCI signs MOU with MedTech Actuator to Build a Commercialization Ecosystem as Legacy of Expo 2025 Osaka, Kansai
Posted: 15 April 2024 On Friday, March 15, the Osaka Chamber of Commerce and Industry (OCCI) is going to sign a Memorandum of Understanding (MOU) with MedTech Actuator – headquartered in Melbourne, Australia – to further expand their partnership. MedTech Actuator is a global…
Florey researchers unlock how to use mRNA to target Alzheimer’s disease
Posted: 15 April 2024 Scientists at The Florey have developed an mRNA technology approach to target the toxic protein tau, which builds up in patients with Alzheimer’s disease and other dementias. To date, mRNA has been predominantly used…
Wound healing is a billion dollar drain on the health system – this discovery hopes to plug it
Posted: 15 April 2024 Scientists have uncovered a key step in the wound healing process that becomes disabled in diseases like diabetes and ageing, contributing to a global healthcare cost of managing poorly healing wounds exceeding $250 billion…
Risk prediction using our genes and gut bacteria can improve early detection of diseases like type 2 diabetes
Posted: 15 April 2024 A new study has shown that risk scores based on our genes and gut bacteria can improve the prediction of diseases such as type 2 diabetes and prostate cancer over traditional risk factors alone.…
Australia’s first purpose-built facility to deliver human challenge trials launches in Melbourne
Posted: 15 April 2024 Australia’s first clinical trial facility specifically commissioned to deliver human challenge trials, Doherty Clinical Trials Ltd, was launched today in East Melbourne by The Honourable Ben Carroll MP Minister for Medical Research and Professor…
Monash’s Parkville campus appoints new head of medicinal chemistry
Posted: 15 April 2024 The Monash Institute of Pharmaceutical Sciences (MIPS), which sits within Monash’s world-leading Faculty of Pharmacy and Pharmaceutical Sciences, has appointed Professor Martin Scanlon as the new Theme Leader for Medicinal Chemistry. MIPS is renowned for its…
Florey discovery could help reduce global shortage of diabetes and weight loss drug semaglutide
Posted: 15 April 2024 Semaglutide is part of the glucagon-like peptide-1 (GLP-1) receptor targeting family of peptide drugs, which are mainly used to treat diabetes but are difficult and expensive to make. An international team of researchers led…
Atmo Biosciences reaches primary endpoints in pivotal clinical study for initial indication
Posted: 11 April 2024 Atmo Biosciences, a company commercializing the world’s first ingestible gas-sensing capsule that provides insights into gut health, is delighted to report that it has successfully reached its primary endpoints in a pivotal clinical study…
